Insilico and Ageing research at King’s partner for health-span and longevity collaboration
IMAGE: Insilico and Ageing Research at King’s enter a research collaboration to enhance health-span and longevity. view more Credit: Insilico Wednesday, May 22 – Insilico Medicine, a biotech company developing the end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, announces its partnership with Ageing Research at King’s (ARK) – dedicated to enhancing multidisciplinary research collaborations across…